AstraZeneca PLC (AZN)
After hours:
| Previous close | 78.52 |
| Open | 78.43 |
| Bid | 78.13 x 200 |
| Ask | 78.16 x 200 |
| Day's range | 78.08 - 79.45 |
| 52-week range | 60.47 - 80.86 |
| Volume | |
| Avg. volume | 4,075,770 |
| Market cap | 243.052B |
| Beta (5Y monthly) | 0.15 |
| PE ratio (TTM) | 37.93 |
| EPS (TTM) | 2.06 |
| Earnings date | 25 July 2024 |
| Forward dividend & yield | 1.45 (1.85%) |
| Ex-dividend date | 22 Feb 2024 |
| 1y target est | 89.57 |
- Yahoo Finance Video
AstraZeneca CEO talks dual supply chain strategy
AstraZeneca (AZN) reported a second-quarter earnings beat, raising its full-year guidance. However, with the upcoming US election potentially impacting operations in regions like China, AstraZeneca CEO Pascal Soriot joins Yahoo Finance reporter Anjalee Khemlani on Catalysts to discuss the company's strategy for navigating these challenges. Soriot outlines AstraZeneca's approach to global expansion, particularly regarding supply chains. He explains that the company is developing two distinct supply chains: one serving Western countries and another "targeted at supplying China and some emerging markets." Importantly, he emphasizes that these two supply chains — the US vs China — will operate "relatively independent from each other." Addressing concerns about the US election's potential impact on operations in China, Soriot notes the company's strategic separation of research and development from manufacturing. This approach allows the company to "source innovation from one part of the world or the other." He acknowledges the diverse policies and rules across different regions, stating that the company adapts its operations accordingly. For more expert insight and the latest market action, click here to watch this full episode of Catalysts. This post was written by Angel Smith
ZacksPharma Stock Roundup: AZN, SNY, ABBV Q2 Earnings, PFE & MRK's Positive Pipeline News
AstraZeneca (AZN), Sanofi (SNY) and AbbVie (ABBV) announce second-quarter results. Merck (MRK) and Pfizer's (PFE) phase III studies achieve primary goals.
Simply Wall St.Top 3 UK Stocks Estimated To Be Undervalued In July 2024
The United Kingdom's stock market has recently experienced declines, influenced by disappointing trade data from China and its broader economic challenges. Amidst these market conditions, identifying undervalued stocks can offer investors potential opportunities for value in a landscape marked by global uncertainties. In this environment, a good stock may be characterized by robust fundamentals such as strong balance sheets and consistent earnings, which provide resilience against ongoing...
